Evidence map›Paper›PMID 37049960›Full record

ArticleMolecules (Basel, Switzerland)2023

Exploring Antimicrobial Features for New Imidazo[4,5-b]pyridine Derivatives Based on Experimental and Theoretical Study.

Mohammed-Yassin Hjouji, Ahmed M Almehdi, Hicham Elmsellem, Yousra Seqqat, Younes Ouzidan, Mohamed Tebbaa, Noura Ait Lfakir, Youssef Kandri Rodi, Fouad Ouazzani Chahdi, Marwa Chraibi and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Mohammed-Yassin HjoujiLaboratory of Applied Organic Chemistry, Faculty of Science and Technology Saiss, Sidi Mohammed Ben Abdallah University, Fez 30050, Morocco.
Ahmed M AlmehdiDepartment of Chemistry, College of Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
Hicham ElmsellemLaboratory of Applied Chemistry and Environment (LCAE), Sciences Faculty, Oujda 60000, Morocco.ORCID 0000-0001-6882-9868
Yousra SeqqatLaboratory of Applied Organic Chemistry, Faculty of Science and Technology Saiss, Sidi Mohammed Ben Abdallah University, Fez 30050, Morocco.
Younes OuzidanLaboratoire de Chimie-Physique et Biotechnologie des Biomolécules et Matériaux, Faculté des Sciences et Techniques, Université Hassan II, BP 146, Mohammedia 28800, Morocco.ORCID 0000-0001-9108-6601
Mohamed TebbaaLaboratoire de Chimie-Physique et Biotechnologie des Biomolécules et Matériaux, Faculté des Sciences et Techniques, Université Hassan II, BP 146, Mohammedia 28800, Morocco.
Noura Ait LfakirLaboratoire de Chimie-Physique et Biotechnologie des Biomolécules et Matériaux, Faculté des Sciences et Techniques, Université Hassan II, BP 146, Mohammedia 28800, Morocco.
Youssef Kandri RodiLaboratory of Applied Organic Chemistry, Faculty of Science and Technology Saiss, Sidi Mohammed Ben Abdallah University, Fez 30050, Morocco.
Fouad Ouazzani ChahdiLaboratory of Applied Organic Chemistry, Faculty of Science and Technology Saiss, Sidi Mohammed Ben Abdallah University, Fez 30050, Morocco.
Marwa ChraibiLaboratory of Microbial Biotechnology, Faculty of Science and Technology Saïss, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco.
Kawtar Fikri BenbrahimLaboratory of Microbial Biotechnology, Faculty of Science and Technology Saïss, Sidi Mohamed Ben Abdellah University, Fez 30050, Morocco.ORCID 0000-0002-2923-9299
Mohamed A Al-OmarDrug Exploration & Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-9866-343X
Abdulrahman A AlmehiziaDrug Exploration & Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0001-8711-3873
Ahmed M NaglahDrug Exploration & Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-4377-5239
Shaima A El-MowafiPeptide Chemistry Department, Chemical Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
Ahmed A ElhenawyChemistry Department, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0003-2893-0376
Sidi Mohamed Ben Abdellah University · MAKing Saud University · SAUniversité Hassan II Mohammedia · MAAl-Azhar University · EGMohamed I University · MANational Research Centre · EGUniversity of Sharjah · AE

Funding

King Saud University RSP-2023R359
6 · The paper itself

Abstract

5-bromopyridine-2,3-diamine reacted with benzaldehyde to afford the corresponding 6-Bromo-2-phenyl-3H-imidazo[4,5-b]pyridine (

Indexed as

Anti-Infective AgentsAnti-Bacterial AgentsGram-Positive BacteriaMolecular ConformationMolecular Docking SimulationPyridinesAnti-Bacterial AgentsAnti-Infective AgentsPyridinesantimicrobial activityCTPDFTimidazo[4,5-b]pyridineN-alkylation

Identifiers

PMID37049960
PMCPMC10096078
OpenAlexW4362560486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.